Dr. Lillian Gelberg, MD, MSPH

Claim this profile
Studies Substance abuse
1 reported clinical trial
3 drugs studied

Clinical Trials Lillian Gelberg, MD, MSPH is currently running

Image of trial facility.

Mobile Health Support

for Substance Use Reduction

The QUIT-Mobile study proposes to use mobile phone self-monitoring and feedback to enhance and sustain over 12-months the impacts of the Quit Using Drugs Intervention Trial (QUIT), an effective screening and brief intervention (SBI) previously successful in reducing risky drug use (i.e., moderate use) in low-income, diverse patients over a 3-month follow up. The investigators will conduct the QUIT-Mobile study for patients who receive care in clinics of federally qualified health centers (FQHC) in Southern California over 12-months follow up. The study is an Effectiveness-Implementation Hybrid Type 1 design consisting of a single-blind, 3-arm, RCT with adult, mostly Latino FQHC primary care patients with risky drug use (ASSIST score 4-26), randomized to 3 conditions (n=200/arm, n=600 total): 1) QUIT-Mobile; 2) standard QUIT; 3) Usual Care. Qualitative data on implementation facilitators and barriers will inform future scale-up and sustainability, in addition to cost data analyses. The aims are to examine effectiveness in reducing risky drug use and cost-effectiveness comparing the three arms over 3-, 6- and 12-months. Drug use measures include self-reports for past 30-days and urine drug screen validation for underreporting (acknowledging that people with moderate risk drug use have sporadic drug use patterns requiring longer self-report recalls for drug use that urine screens may not detect). The 3-arm study enables testing of the independent and synergistic effects of QUIT-Mobile compared to QUIT and both to Usual Care. The 12-month timeline reflects annual primary care visits when screening and brief intervention would be repeated routinely. The QUIT intervention contains 3 primary components: 1) patient screening with the WHO ASSIST, 2) brief clinician advice (\<3 minutes) including opioid overdose prevention education, and 3) 2- and 6-week telephone drug-use health coaching sessions utilizing motivational interviewing and cognitive behavioral techniques, delivered by paraprofessional health coaches. QUIT-Mobile tests the addition of mobile phone self-monitoring, automated feedback, and coach monitoring dashboard to enhance and sustain QUIT\'s drug use reductions using mobile-web app, text-messaging (SMS), or interactive voice response (IVR).
Recruiting1 award N/A

More about Lillian Gelberg, MD, MSPH

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Lillian Gelberg, MD, MSPH has experience with
  • QUIT Intervention (doctor Brief Advice, Video Doctor, Health Coaching Sessions At 2- And 6-weeks)
  • QUIT-Mobile (QUIT Intervention Plus Weekly Mobile-web App Or Text Message Weekly Self-monitoring, Automated Feedback Over 12 Months)
  • Usual Care
Breakdown of trials Lillian Gelberg, MD, MSPH has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lillian Gelberg, MD, MSPH specialize in?
Lillian Gelberg, MD, MSPH focuses on Substance abuse and other conditions. In particular, much of their work with Substance abuse has involved treating patients, or patients who are undergoing treatment.
Is Lillian Gelberg, MD, MSPH currently recruiting for clinical trials?
Yes, Lillian Gelberg, MD, MSPH is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Lillian Gelberg, MD, MSPH has studied deeply?
Yes, Lillian Gelberg, MD, MSPH has studied treatments such as QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks), QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months), Usual Care.
What is the best way to schedule an appointment with Lillian Gelberg, MD, MSPH?
Apply for one of the trials that Lillian Gelberg, MD, MSPH is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.